Enzyme will facilitate access to innovation for the development of digital solutions based on AWS Cloud services to help businesses and organizations in the healthcare sector reduce costs, increase agility, and innovate faster.
Barcelona, february 21, 2022. - Enzyme Advising Group, a company specialized in accelerating the growth of companies through Artificial Intelligence, data and blockchain technology, announced today an expansion of its strategic partnership with Amazon Web Services (AWS), the world's most adopted cloud technology provider, to accelerate the adoption of cloud solutions in the healthcare sector.
With this collaboration both companies, which have previously collaborated in the creation of applications in the cloud, will promote the commercialization of Komombo, the platform developed together with the Hospital Clínic de Barcelona and other leading hospitals that tackles precision medicine, one of the most effective ways to prevent diseases. Komombo accelerates the diagnosis of respiratory diseases in a collaborative way, preserving the privacy of information and improving the quality of life for patients. This is achieved through artificial intelligence algorithms and machine learning. This technology can be applied to multiple pathologies, which represents a very important advance in the medical field.
Komombo’s flexibility adapts to the technology requirements of each hospital. With this collaboration, AWS will be the reference cloud infrastructure provider for Komombo, which already has its central node developed in AWS.
Enzyme is able to integrate solutions in hospitals quickly and efficiently thanks to technological developments and the new features and innovative services provided by AWS. José A. Torre, CTO of Enzyme, comments that "having solutions in the AWS cloud is a considerable advantage for Enzyme solutions in the healthcare sector."
Enzyme’s experience with Computer Vision technology and Artificial intelligence in the healthcare sector includes award winning projects such as Hipra's Smart Diagnosis Platform, an AI based diagnostic imaging solution that facilitates the process of creating new visual diagnostic tools for the animal health industry.
Within the framework of this collaboration, Enzyme and AWS plan on organizing and participating in healthcare sector events.
Álvaro Ortín, CEO of Enzyme declares “being able to collaborate with AWS is fully aligned with our platform strategy in the healthcare sector. The combination of Komombo with AWS is the solution that responds to the needs of hospitals that seek to optimize their processes with AI technology and position themselves as innovative centers in an increasingly complex environment.”
